DocGo Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 199.25 million compared to USD 108.78 million a year ago. Net income was USD 7.57 million compared to USD 8.06 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.01 USD | -0.99% | -8.79% | -46.15% |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.15% | 309M | |
+1.21% | 3.14B | |
0.00% | 1.96B | |
+19.29% | 1.79B | |
+70.11% | 695M | |
-19.78% | 170M | |
-15.65% | 134M | |
+3.85% | 67.96M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023